MJ
Mayank Jayantilal Shah
About Mayank Jayantilal Shah
Data last updated:
Mayank Jayantilal Shah is a Director at Diabetomics Medical Private Limited (since 2026) and Director at Rivaara Immune Private Limited (since 2023). The companies operate in Healthcare, Financial Services and Energy and Power. The 2 current companies with reported revenue have a combined latest revenue of ₹9.31 Cr; the largest is Diabetomics Medical Private Limited at ₹9.31 Cr (FY 2025). Earlier, Mayank Jayantilal Shah was a Partner at Dolat Absolute Return Llp (2021–2022) and Managing Director at Waaree Renewable Technologies Limited (2017–2019) and 19 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Apr 2026 | 2015 | ₹9.31 Cr (FY 2025) | Active | |
| Director | 26 Dec 2023 | 2019 | ₹1,550 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 29 Jan 2021 | 2020 | ₹37.07 Cr (FY 2025) | Active | |
| Managing Director | 14 Nov 2017 | 1999 | ₹1,613 Cr (FY 2025) | Active | |
| Director | 30 Sep 2015 | 2007 | ₹396 Cr (FY 2019) | Amalgamated | |
| Alternate Director | 01 Aug 1996 | 1995 | ₹199 Cr (FY 2025) | Active | |
| Nominee Director | 18 Jul 2018 | 2018 | Amalgamated | ||
| Cfo | 28 Jul 2014 | 2014 | ₹110 Cr (FY 2025) | Active | |
| Nominee Director | 29 Aug 2018 | 2018 | ₹29.4 Lakh (FY 2025) | Active | |
| Director | 01 Apr 2008 | 2008 | ₹56 Lakh (FY 2025) | Active | |
| Director | 13 Oct 2015 | 2015 | Strike Off | ||
| Director | 29 Sep 1995 | 1995 | Dissolved (Liquidated) | ||
| Director | 06 Nov 2009 | 2009 | Strike Off | ||
| Director | 29 Sep 1995 | 1982 | Dissolved (Liquidated) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mayank Jayantilal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Indrapal Reddy Sathireddy Addela | 03341993 | Diabetomics Medical Private Limited | Director |
| Siddharth Bharat Daftary | 02897197 | Diabetomics Medical Private Limited , Rivaara Immune Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayank Jayantilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayank Jayantilal Shah
Mayank Jayantilal Shah currently holds 2 directorships: Diabetomics Medical Private Limited (Director, since 22 Apr 2026, revenue ₹9.31 Cr (FY 2025)); Rivaara Immune Private Limited (Director, since 26 Dec 2023, revenue ₹1,550 (FY 2025)).
Mayank Jayantilal Shah was first appointed on 29 Sep 1995 as Director at Curlew Finance And Investments Private Limited. The most recent appointment on record is 22 Apr 2026 at Diabetomics Medical Private Limited.
The 2 current companies of Mayank Jayantilal Shah that report revenue have a combined latest revenue of ₹9.31 Cr: Diabetomics Medical Private Limited ₹9.31 Cr (FY 2025); Rivaara Immune Private Limited ₹1,550 (FY 2025).
Mayank Jayantilal Shah held 21 earlier board appointments: Dolat Absolute Return Llp (Partner, 29 Jan 2021 to 29 Sep 2022); Waaree Renewable Technologies Limited (Managing Director, 14 Nov 2017 to 30 Mar 2019); Reliance Lifestyle Holdings Limited (Director, 30 Sep 2015 to 31 Aug 2019); Arya Omnitalk Wireless Solutions Private Limited (Alternate Director, 01 Aug 1996 to 05 Sep 2009); Waasang Solar Private Limited (Nominee Director, 18 Jul 2018 to 30 Mar 2019); and 16 more.
The current boards of Mayank Jayantilal Shah's companies include Indrapal Reddy Sathireddy Addela (Diabetomics Medical Private Limited), Siddharth Bharat Daftary (Diabetomics Medical Private Limited).